These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 37567492)
1. NLRC4 gain-of-function variant is identified in a patient with systemic lupus erythematosus. Wang Q; Ye X; Zheng W; Jin T; Zhou Y; Hu X; Zhou Q; Yu X Clin Immunol; 2023 Oct; 255():109731. PubMed ID: 37567492 [TBL] [Abstract][Full Text] [Related]
3. A Novel Mutation in the NBD Domain of Wang L; Wen W; Deng M; Li Y; Sun G; Zhao X; Tang X; Mao H Front Immunol; 2021; 12():674808. PubMed ID: 34248956 [TBL] [Abstract][Full Text] [Related]
4. An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome. Canna SW; de Jesus AA; Gouni S; Brooks SR; Marrero B; Liu Y; DiMattia MA; Zaal KJ; Sanchez GA; Kim H; Chapelle D; Plass N; Huang Y; Villarino AV; Biancotto A; Fleisher TA; Duncan JA; O'Shea JJ; Benseler S; Grom A; Deng Z; Laxer RM; Goldbach-Mansky R Nat Genet; 2014 Oct; 46(10):1140-6. PubMed ID: 25217959 [TBL] [Abstract][Full Text] [Related]
5. Three cases of autoinflammatory disease with novel NLRC4 mutations, and the first mutation reported in the CARD domain of NLRC4 associated with autoinflammatory infantile enterocolitis (AIFEC). Asna Ashari K; Parvaneh N; Mirnia K; Ayati M; Saeedi M; Salehzadeh F; Shahrooei M; Sangsari R; Rohani P; Ziaee V Pediatr Rheumatol Online J; 2024 Oct; 22(1):90. PubMed ID: 39425177 [TBL] [Abstract][Full Text] [Related]
11. Rapamycin as an Adjunctive Therapy for NLRC4 Associated Macrophage Activation Syndrome. Barsalou J; Blincoe A; Fernandez I; Dal-Soglio D; Marchitto L; Selleri S; Haddad E; Benyoucef A; Touzot F Front Immunol; 2018; 9():2162. PubMed ID: 30319625 [TBL] [Abstract][Full Text] [Related]
12. An inherited mutation in NLRC4 causes autoinflammation in human and mice. Kitamura A; Sasaki Y; Abe T; Kano H; Yasutomo K J Exp Med; 2014 Nov; 211(12):2385-96. PubMed ID: 25385754 [TBL] [Abstract][Full Text] [Related]
13. The autoinflammation-associated NLRC4 Eeckhout E; Asaoka T; Van Gorp H; Demon D; Girard-Guyonvarc'h C; Andries V; Vereecke L; Gabay C; Lamkanfi M; van Loo G; Wullaert A Front Immunol; 2023; 14():1272639. PubMed ID: 38090573 [TBL] [Abstract][Full Text] [Related]
14. Blockade of anti-dsDNA ameliorates systemic lupus erythematosus in MRL/Faslpr mice through ameliorating inflammation via the PKCδ-NLRC4 axis. Yang F; Yang Y; Zeng W Biochem Cell Biol; 2021 Jun; 99(3):313-321. PubMed ID: 33064961 [TBL] [Abstract][Full Text] [Related]
19. A novel de novo NLRC4 mutation reinforces the likely pathogenicity of specific LRR domain mutation. Chear CT; Nallusamy R; Canna SW; Chan KC; Baharin MF; Hishamshah M; Ghani H; Ripen AM; Mohamad SB Clin Immunol; 2020 Feb; 211():108328. PubMed ID: 31870725 [TBL] [Abstract][Full Text] [Related]
20. NLRC4, ASC and Caspase-1 Are Inflammasome Components that Are Mediated by P2Y Jin H; Kim HJ Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32397236 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]